However, it is worth noting that CA125/CEA ratio ≥25 was significantly associated with primary and non-metastatic ovarian tumors, relative risk (RR) = 2.4, 95% CI, 1.3–4.6 [15]. This evidence concerns the gene CEACAM5 and ovarian neoplasm.